259 related articles for article (PubMed ID: 26232517)
1. Postoperative hormone replacement therapy for epithelial ovarian cancer patients: a systematic review and meta-analysis.
Li D; Ding CY; Qiu LH
Gynecol Oncol; 2015 Nov; 139(2):355-62. PubMed ID: 26232517
[TBL] [Abstract][Full Text] [Related]
2. The safety of postoperative hormone replacement therapy in epithelial ovarian cancer patients in China.
Wen Y; Huang H; Huang H; Wu M; Shen K; Pan L
Climacteric; 2013 Dec; 16(6):673-81. PubMed ID: 23710587
[TBL] [Abstract][Full Text] [Related]
3. Use of hormone replacement therapy before and after ovarian cancer diagnosis and ovarian cancer survival.
Mascarenhas C; Lambe M; Bellocco R; Bergfeldt K; Riman T; Persson I; Weiderpass E
Int J Cancer; 2006 Dec; 119(12):2907-15. PubMed ID: 16998830
[TBL] [Abstract][Full Text] [Related]
4. Systematic lymphadenectomy for survival in epithelial ovarian cancer: a meta-analysis.
Kim HS; Ju W; Jee BC; Kim YB; Park NH; Song YS; Kim SC; Kang SB; Kim JW
Int J Gynecol Cancer; 2010 May; 20(4):520-8. PubMed ID: 20686371
[TBL] [Abstract][Full Text] [Related]
5. Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta-analysis.
Poggio F; Del Mastro L; Bruzzone M; Ceppi M; Razeti MG; Fregatti P; Ruelle T; Pronzato P; Massarotti C; Franzoi MA; Lambertini M; Tagliamento M
Breast Cancer Res Treat; 2022 Jan; 191(2):269-275. PubMed ID: 34731351
[TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy in cancer survivors: Utopia?
Angioli R; Luvero D; Armento G; Capriglione S; Plotti F; Scaletta G; Lopez S; Montera R; Gatti A; Serra GB; Benedetti Panici P; Terranova C
Crit Rev Oncol Hematol; 2018 Apr; 124():51-60. PubMed ID: 29548486
[TBL] [Abstract][Full Text] [Related]
7. The oncologic impact of hormone replacement therapy in premenopausal breast cancer survivors: A systematic review.
Wang Y; Lewin N; Qaoud Y; Rajaee AN; Scheer AS
Breast; 2018 Aug; 40():123-130. PubMed ID: 29763858
[TBL] [Abstract][Full Text] [Related]
8. Reproductive factors and epithelial ovarian cancer survival in the EPIC cohort study.
Bešević J; Gunter MJ; Fortner RT; Tsilidis KK; Weiderpass E; Onland-Moret NC; Dossus L; Tjønneland A; Hansen L; Overvad K; Mesrine S; Baglietto L; Clavel-Chapelon F; Kaaks R; Aleksandrova K; Boeing H; Trichopoulou A; Lagiou P; Bamia C; Masala G; Agnoli C; Tumino R; Ricceri F; Panico S; Bueno-de-Mesquita HB; Peeters PH; Jareid M; Quirós JR; Duell EJ; Sánchez MJ; Larrañaga N; Chirlaque MD; Barricarte A; Dias JA; Sonestedt E; Idahl A; Lundin E; Wareham NJ; Khaw KT; Travis RC; Rinaldi S; Romieu I; Riboli E; Merritt MA
Br J Cancer; 2015 Dec; 113(11):1622-31. PubMed ID: 26554655
[TBL] [Abstract][Full Text] [Related]
9. Effects of hormone replacement therapy on the rate of recurrence in endometrial cancer survivors: a meta-analysis.
Shim SH; Lee SJ; Kim SN
Eur J Cancer; 2014 Jun; 50(9):1628-37. PubMed ID: 24685478
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the prognostic significance of preoperative thrombocytosis in epithelial ovarian cancer.
Allensworth SK; Langstraat CL; Martin JR; Lemens MA; McGree ME; Weaver AL; Dowdy SC; Podratz KC; Bakkum-Gamez JN
Gynecol Oncol; 2013 Sep; 130(3):499-504. PubMed ID: 23747328
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Postoperative Hormone Replacement Therapy on Prognosis of Patients with Serous Ovarian Carcinoma.
Zhang YL; Chen JH; Lu W; Li BL; Zhu QY; Wan XP
Chin Med J (Engl); 2016 Jun; 129(11):1316-21. PubMed ID: 27231169
[TBL] [Abstract][Full Text] [Related]
12. The survival detriment of venous thromboembolism with epithelial ovarian cancer.
Gunderson CC; Thomas ED; Slaughter KN; Farrell R; Ding K; Farris RE; Lauer JK; Perry LJ; McMeekin DS; Moore KN
Gynecol Oncol; 2014 Jul; 134(1):73-7. PubMed ID: 24793732
[TBL] [Abstract][Full Text] [Related]
13. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival of epithelial ovarian cancer: a systematic review and meta-analysis of observational studies.
Yang Z; Gu JH; Guo CS; Li XH; Yang WC
Oncotarget; 2017 Jul; 8(28):46414-46424. PubMed ID: 28423365
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women.
Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Weiderpass E; Persson IR
J Natl Cancer Inst; 2002 Apr; 94(7):497-504. PubMed ID: 11929950
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of preoperative leukocytosis in epithelial ovarian carcinoma: a retrospective cohort study.
So KA; Hong JH; Jin HM; Kim JW; Song JY; Lee JK; Lee NW
Gynecol Oncol; 2014 Mar; 132(3):551-5. PubMed ID: 24440470
[TBL] [Abstract][Full Text] [Related]
16. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
17. Hormone replacement therapy formulations and risk of epithelial ovarian carcinoma.
Sit AS; Modugno F; Weissfeld JL; Berga SL; Ness RB
Gynecol Oncol; 2002 Aug; 86(2):118-23. PubMed ID: 12144815
[TBL] [Abstract][Full Text] [Related]
18. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
19. Lymphadenectomy for primary ovarian cancer: a systematic review and meta-analysis.
Chiyoda T; Sakurai M; Satoh T; Nagase S; Mikami M; Katabuchi H; Aoki D
J Gynecol Oncol; 2020 Sep; 31(5):e67. PubMed ID: 32808497
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of an international multicenter study comprising 545 patients.
Bentivegna E; Fruscio R; Roussin S; Ceppi L; Satoh T; Kajiyama H; Uzan C; Colombo N; Gouy S; Morice P
Fertil Steril; 2015 Nov; 104(5):1319-24. PubMed ID: 26149354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
